Rutgers Business School To Host Its First Biopharmaceutical Case Competition
NEWARK, N.J., Nov. 8, 2012 /PRNewswire-USNewswire/ -- Nearly a year after one of its teams of MBA students swept one of the most prestigious pharmaceutical case competitions in the country, Rutgers Business School is turning host.
Teams from 11 business schools, including Georgetown and Columbia, have signed up to compete in the school's first biopharmaceutical case competition.
The day-long competition will be held November 10 at Rutgers Business School's $83 million facility, 1 Washington Park, at Rutgers University's campus in Newark, New Jersey.The teams will be competing for cash prizes as well as the recognition of some of the industry's leading companies. "It brings another layer of national exposure to the school,'' said Chris Parker, a Rutgers MBA student who competed at Kellogg School of Management earlier this year. As co-president of the pharmaceutical club, Parker helped to organize the competition being hosted by Rutgers. Parker said Rutgers will follow what has become "the gold standard'' for pharmaceutical case competitions: Each team will have a week to prepare after receiving a case study that reflects a current, real-life marketing or operational issue faced by the industry. The teams will be judged on their presentations by a panel made up of representatives from each of the seven companies that have agreed to sponsor the competition. "It's very intense. There's a lot of ground to cover in a short time,'' Parker said. "But it's a chance to bring your expertise to life in a way the interview process does not bring to light." Rutgers won last year at Kellogg School of Management, one of the premiere case competitions in the country. And Parker helped a team from Rutgers Business School win honorable mention at Kellogg's competition earlier this year. The case competitions provide students with an opportunity to demonstrate their knowledge and skills to prospective employers and to network among both students and industry professionals. Leading pharmaceutical and healthcare companies, which often sponsor the events, use the events to identify new talent.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV